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Oxidative/Antioxidant BalanceBilirubin is generally regarded as a compound which is toxic
to the central nervous system, and oxidative stress is
emerging as a relevant event in the mechanism of bilirubin-
associated encephalopathy. However, in recent years,
studies have demonstrated that bilirubin may also exhibit
potent antioxidant properties. This was supported by the
notion that serum bilirubin increases in response to initial
oxidative stress and its role as an efficient scavenger of
reactive oxygen species was well documented. Dogan et al1
suggested that the relationship between serum total bili-
rubin and antioxidant/oxidative stress could be expressed
by a quadratic correlation curve. Thus, the role of bilirubin
in the antioxidant panel and the oxidative stress parameter
remained a conflicting issue to be further explored. As for
the treatment of severe hyperbilirubinemia, phototherapy
is currently the most widely used form of therapy. However,
reports have shown that oxidant/antioxidant balance is also
disturbed during such practice, as some results indicated an
increased oxidative stress index after phototherapy.2,3
Thus, the role of phototherapy in the oxidant/antioxidant
status also remains an important topic to be further
discussed.
Many studies that investigated the oxidative/antioxidant
status in infants with hyperbilirubinemia were mostly
comprised of measurements of plasma total antioxidant ca-
pacity, serum total oxidant status, and malondialdehyde
(MDA).1,4 Measurement of novel parameters of oxidative
stress such as advanced oxidative protein product (AOPP) and
S100B were mostly used to evaluate the severity of intra-
ventricular hemorrhage or severe hypoxic brain injury.5,6 In
this issue of Pediatrics and Neonatology, Sarici and col-
leagues7 were among the first ones to relate AOPPs and S100B
with hyperbilirubinemia and phototherapy. In addition to
further clarifying and consolidating the existing knowledge
about the role of MDA in severe hyperbilirubinemia, the au-
thors also attempted to investigate the effect of photo-
therapy on serum MDA level. The results showed a positive
correlation between MDA and S100B with elevated serum
bilirubin level, suggesting an increased oxidative stress inhttp://dx.doi.org/10.1016/j.pedneo.2015.01.001
1875-9572/Copyright ª 2015, Taiwan Pediatric Association. Published binfants with significant hyperbilirubinemia. However, AOPP
did not seem to be associated with serum bilirubin level. One
possible explanation might be that, because infants with a
critically higher serum bilirubin level (including those with
kernicterus) were not included in this study, it is possible that
changes in AOPP level might only be significant in cases with
early-phase bilirubin encephalopathy. However, the signifi-
cant decrease in AOPP level after phototherapy suggested
that phototherapy per se might have an antioxidant pro-
pensity, as it was often argued that the antioxidant effect of
phototherapy was the result of a reduced serum bilirubin
level.
There are several limitations in this study. First, the
population number was too small to make any definite
conclusions. Second, although the authors had demon-
strated similar characteristics between the study groups
(severe hyperbilirubinemia vs. controls), causes for infants’
jaundice were not clearly stated, so adjustments for po-
tential confounding factors related to hyperbilirubinemia
were not made during statistical calculation. Hence, the
accuracy of the statistical results remains questionable.
Third, cases with hemolytic anemia, G6PD deficiency, and
kernicterus were not included in this study, which might
cause discrepancies in the results due to selection bias,
since hemolytic anemia and G6PD deficiency are often
causes of severe hyperbilirubinemia, and infants with ker-
nicterus might be at greater risk for oxidative stress related
to brain damage.
Although several attempts have been made to survey the
role of bilirubin in the oxidative/antioxidant balance,
currently none has reached a definitive conclusion as to
whether bilirubin has an antioxidant capacity or causes
oxidative stress leading to encephalopathy. The study of
Sarici et al7 provides additional information regarding the
effect of bilirubin and phototherapy in the oxidative/anti-
oxidant balance. Their results are in favor of a positive
correlation between hyperbilirubinemia and oxidative
stress and provide evidence that recognizes the antioxidant
efficacy of intensive phototherapy.y Elsevier Taiwan LLC. All rights reserved.
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